E-LIB Suche - Ergebnisse für: Rustgi, V.K.

1

EE508 Cost of Liver Cancer Screening in Patients with Cirrh..:

Samur, S. ; Rustgi, V.K. ; Parikh, N.D....
Value in Health. 26 (2023) 6 - p. S152 , 2023

Link: https://doi.org/10.1016/..

2

Virological outcomes and treatment algorithms utilisation i..:

Sterling, R. K. ; Kuo, A. ; Rustgi, V. K....
Alimentary Pharmacology & Therapeutics. 41 (2015) 7 - p. 671-685 , 2015

Link: https://doi.org/10.1111/..

3

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROT..:

Everson, G.T. ; Di Bisceglie, A.M. ; Vierling, J.M....
Journal of Hepatology. 58 (2013) - p. S6 , 2013

Link: https://doi.org/10.1016/..

4

1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBIT..:

Bronowicki, J.-P. ; Pol, S. ; Thuluvath, P....
Journal of Hepatology. 56 (2012) - p. S431-S432 , 2012

Link: https://doi.org/10.1016/..

5

1373 FIRST REPORT OF SVR12 FOR A NS5A REPLICATION COMPLEX I..:

Pol, S. ; Ghalib, R.H. ; Rustgi, V.K....
Journal of Hepatology. 54 (2011) - p. S544-S545 , 2011

Link: https://doi.org/10.1016/..

6

1195 BMS-650032, AN NS3 INHIBITOR, IN COMBINATION WITH PEGI..:

Bronowicki, J.-P. ; Pol, S. ; Thuluvath, P.J....
Journal of Hepatology. 54 (2011) - p. S472 , 2011

Link: https://doi.org/10.1016/..

7

778 PHASE IIB STUDY OF BALAPIRAVIR (RG1626; NUCLEOSIDE ANAL..:

Zeuzem, S. ; Nelson, D.R. ; Andreone, P....
Journal of Hepatology. 52 (2010) - p. S302-S303 , 2010

Link: https://doi.org/10.1016/..

8

2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED S..:

Bacon, B.R. ; Shiffman, M.L. ; Lim, J.K....
Journal of Hepatology. 52 (2010) - p. S463 , 2010

Link: https://doi.org/10.1016/..

9

2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION..:

Lawitz, E. ; Rodriquez-Torres, M. ; Rustgi, V.K....
Journal of Hepatology. 52 (2010) - p. S467 , 2010

Link: https://doi.org/10.1016/..

10

Peginterferon alfa‐2a/ribavirin in hepatitis C virus patien..:

RUSTGI, V. K. ; ESPOSITO, S. ; HAMZEH, F. M..
Alimentary Pharmacology & Therapeutics. 27 (2007) 5 - p. 433-440 , 2007

Link: https://doi.org/10.1111/..

11

Early virologic response after peginterferon alpha‐2a plus ..:

Di Bisceglie, A. M. ; Ghalib, R. H. ; Hamzeh, F. M..
Journal of Viral Hepatitis. 14 (2007) 10 - p. 721-729 , 2007

Link: https://doi.org/10.1111/..

12

Pharmacokinetics and biochemical effects of hepapoietin in ..:

Marino, G. ; Rustgi, V. K. ; Salzberg, G....
Alimentary Pharmacology & Therapeutics. 16 (2002) 2 - p. 235-242 , 2002

Link: https://doi.org/10.1046/..

13

Impact of donor age on graft survival among liver transplan..:

Rustgi, S.D ; Marino, G ; Halpern, M.T...
Transplantation Proceedings. 34 (2002) 8 - p. 3295-3297 , 2002

Link: https://doi.org/10.1016/..

14

ACTIVATION OF NF-κB IN HEPATITIS C VIRUS INFECTED LIVER ALL..:

Gaweco, A S ; Wiesner, R H ; Rustgi, V K...
Transplantation. 67 (1999) 7 - p. S113 , 1999

Link: https://doi.org/10.1097/..

15

1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN..:

Everson, G.T. ; Sims, K.D. ; Rodriguez-Torres, M....
Journal of Hepatology. 58 (2013) - p. S573 , 2013

Link: https://doi.org/10.1016/..